An international research project brought together scientists from the Federal University of São Paulo (UNIFESP) and São Paulo State University (UNESP) in Brazil and the University of Colorado Anschutz in the United States.
The group evaluated the Ac2-26 peptide, which is part of an anti-inflammatory protein called Annexin A1, in experimental models that simulate the human eye. The tests were conducted on cell cultures isolated from the retina and on three-dimensional structures that function as “mini-retinas” (organoids), both of which were derived from patients’ stem cells.